Delivery Order SPE2DB20D2104-SPE2DB25FMPAF
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,967.18 to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count supply) on May 8, 2025, with an ultimate completion date of May 9, 2025. This is a firm fixed-price, non-set-aside contract with performance at the vendor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the Defense Logistics Agency....
- The Defense Logistics Agency awarded a delivery order valued at $1,337.06 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, indicating competitive award. The product will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles). The contract, valued at $4,273.24, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract carries a ceiling value of $6,471.99 and firm fixed pricing terms, with an ultimate completion date of August 26, 2025. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a contract value of $4,997.88. This competitively awarded, non-set-aside delivery order is classified as firm fixed price and carries an ultimate completion date of April 25, 2025. The award was issued on April 24, 2025, and represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $1,175.41. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.86 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $1,425.93. This firm fixed-price delivery order, which is expected to be completed by September 12, 2025, represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a contract ceiling value of $6,090.09. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMPAFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $4,739.35. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's comprehensive IDC vehicle enables it to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for diabetes, neurological conditions, pain management, and antibiotics. The DLA Troop Support Medical contract supports various federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, with AmerisourceBergen positioned as a primary pharmaceutical vendor under the broader Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 4/21/25 |